Solalta Advisors exists to assist companies and institutions with commercial development of early-stage technologies and products. We do this by carrying out scientific, market and commercial due diligence of biotechnology, pharmaceutical, nutraceutical, chemical and environmental technologies and potential commercial partners. We also assist with technology transfer and licensing; project and portfolio management; business planning, development and management services.
We provide the rare perspective of both venture capital investment and early stage product development in the human life-sciences market. This enables Solalta Advisors to provide effective due diligence of early stage opportunities and to help prepare those with early stage technologies to obtain funding as they convert their technologies into products. We are able to assist in the identification of product opportunities and the market drivers that will enable your products to be positioned for success as they move through development.
Moving ideas from conception or research into products that can be used to improve lives is a long, complicated and expensive process that has an incredibly high failure rate. Solalta was set up to assist in the commercial assessment of technologies and to provide guidance in their development.
Our Staff
Solalta History
